David R. Anderson,Robert A. Volkmann,Frank S. Menniti,Christopher Fanger
申请号：
US16060294
公开号：
US10500205B2
申请日:
2016.12.09
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the NMDA receptor.
